LY-301317, also known as (R)-4,α-methylene-5-(1,3-oxazol-5-yl)-N,N-dipropyltryptamine ((R)-4,α-methylene-5-(1,3-oxazol-5-yl)-DPT), is a potent and selective serotonin 5-HT1A receptor agonist which has been used in scientific research. It is a cyclized tryptamine and a partial ergoline. The drug shows very high affinity for the serotonin 5-HT1A receptor, with a Ki of 0.26 nM, and is highly selective for this receptor over 9 other assessed targets. It produces various serotonin 5-HT1A receptor agonist-associated effects in animals, including behavioral effects, hypothermia, antidepressant-like, anxiolytic-like, and antiemetic effects, and discriminative stimulus effects in drug discrimination tests. LY-301317 was first described in the scientific literature in 1996.
See also Partial ergoline Cyclized tryptamine LY-178210 (LY-228729) LY-293284
References


